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ABSTRACT
Objectives To pilot a complex intervention to support 
healthcare and improve early detection and treatment for 
common health conditions experienced by nursing home 
(NH) residents.
Design Pilot cluster randomised controlled trial.
Setting 14 NHs (7 intervention, 7 control) in London and 
West Yorkshire.
Participants NH residents, their family carers and staff.
Intervention Complex intervention to support healthcare 
and improve early detection and treatment of urinary 
tract and respiratory infections, chronic heart failure and 
dehydration, comprising: (1) ‘Stop and Watch (S&W)’ early 
warning tool for changes in physical health, (2) condition- 
specific care pathway and (3) Situation, Background, 
Assessment and Recommendation tool to enhance 
communication with primary care. Implementation was 
supported by Practice Development Champions, a Practice 
Development Support Group and regular telephone 
coaching with external facilitators.
Outcome measures Data on NH (quality ratings, 
size, ownership), residents, family carers and staff 
demographics during the month prior to intervention 
and subsequently, numbers of admissions, accident and 
emergency visits, and unscheduled general practitioner 
visits monthly for 6 months during intervention. We 
collected data on how the intervention was used, 
healthcare resource use and quality of life data for 
economic evaluation. We assessed recruitment and 
retention, and whether a full trial was warranted.
Results We recruited 14 NHs, 148 staff, 95 family carers 
and 245 residents. We retained the majority of participants 
recruited (95%). 15% of residents had an unplanned 
hospital admission for one of the four study conditions. We 
were able to collect sufficient questionnaire data (all over 
96% complete). No NH implemented intervention tools as 
planned. Only 16 S&W forms and 8 care pathways were 
completed. There was no evidence of harm.
Conclusions Recruitment, retention and data collection 
processes were effective but the intervention not 
implemented. A full trial is not warranted.
Trial registration number ISRCTN74109734 (https:// doi. 
org/ 10. 1186/ ISRCTN74109734).
Original protocol BMJ Open. 2019;9(5):e026510. 
doi:10.1136/bmjopen-2018-026510.
INTRODUCTION
Currently in the UK more than 420 000 
people aged over 65 years live in residential 
care, of which approximately 220 000 reside 
in care homes with nursing (referred to in 
this paper as ‘nursing homes’ (NHs)).1 Most 
UK NHs are owned by private companies 
and residents pay on a means- tested basis. 
Unlike some European NHs, for example in 
the Netherlands, there is no on- site provision 
of medical care. NH residents are served by 
a general practitioner and other visiting staff 
Strengths and limitations of this study
 ► The intervention was adapted from a successful US 
programme, co- designed with residents, family car-
ers and staff to fit with the UK nursing home context.
 ► Successful recruitment and retention of nurs-
ing homes, their staff, residents and family carers 
demonstrated the feasibility of our study methods.
 ► It was challenging to collect reliable data on hospi-
tal admissions, ambulance and general practitioner 
visits.
 ► The nature of the intervention in this cluster ran-
domised trial meant that outcome data were not 
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such as specialist nurses. NH residents have complex 
healthcare needs with high levels of multimorbidity, 
frailty and dementia. The King’s Fund2 and British Geriat-
rics Society3 have raised concerns about the inconsistency 
and quality of healthcare provision to NHs.
There has been a 63% increase in all- cause hospital 
admissions from NHs between 2011 and 2015.4 As well 
as causing distress to residents, their families and staff, 
hospitalisation is expensive for health and social care 
systems, costing an estimated £1.2 billion per- annum in 
the UK.5 Hospital admission increases risk of decline in 
functional ability, delirium, adverse events and prolonged 
stays.6 7
Ambulatory Care Sensitive Conditions (ACSCs) are 
‘conditions that can lead to unplanned hospital admis-
sions that may have been avoidable or manageable by 
timely access to medical care in the community’.8 9 Four 
ACSCs contribute to a 30% of hospitalisations from NHs5: 
respiratory infections8 10–12; acute exacerbation of chronic 
heart failure (CHF)13 14; urinary tract infections (UTIs)8 15 
and dehydration.8
A number of interventions have been developed to 
enhance healthcare in NHs, falling broadly into two cate-
gories: single component interventions (predominantly 
advanced care planning or single- disease care pathways, 
eg, for pneumonia) and multicomponent interventions 
which include enhancing staff knowledge and skills,16 clin-
ical guidance and decision- support tools (care pathways), 
engaging with families,17 and input from geriatricians or 
nurse practitioners.18 Research highlights the importance 
of collaborative intervention development with staff,19 
residents and families,17 and using local champions to 
support implementation.14 ‘INTERACT’ (Interventions 
to Reduce Acute Care Transfers), developed in the USA, 
focuses on managing acute changes in residents’ condi-
tion and reduces transfers to acute hospitals.14 We worked 
with stakeholders and our family Carer Reference Panel 
(CRP) to develop and adapt INTERACT for use in the 
UK.20 This included 18 semistructured interviews and 
three co- design workshops over 5 months, with amend-
ments made to the intervention after each workshop. 
Participants comprised 22 diverse stakeholders (two NH 
managers, three care assistants, eight nurses, four general 
practitioners, three family carers, a geriatrician and a 
quality improvement manager) (paper in preparation). 
The Promoting Action on Research Implementation 
in Health Services (PARiHS) framework underpinned 
co- design of implementation support and guidance.21
Aim and objectives
Our aim was to indicate whether a definitive study of the 
Better Health in Residents of Care Homes with Nursing 
(BHiRCH- NH) intervention is warranted.
Primary objective
To indicate whether the intervention was acceptable and 
feasible.
Secondary objectives
1. Establish whether consent procedures facilitate collec-
tion of sufficient individual- level data.
2. Assess intervention fidelity.
3. Assess the effectiveness of the implementation strategy 
and level of staff engagement with the intervention.
4. Indicate whether the intervention would be sustain-
able outside the trial context.
5. Assess potential primary and secondary outcome mea-
sures for a definitive trial.
6. Measure completeness of data collection, documenta-
tion, return rate of questionnaires, and assess potential 
primary and secondary outcomes for a definitive trial.




A pilot cluster randomised trial in NHs, conducted and 
reported as per the Consolidated Standards of Reporting 
Trials guidance.22 Detailed methods are described in the 
trial protocol paper.20 The NH was the unit of allocation 
(seven intervention and seven control sites).
Patient and public involvement
The project was developed in collaboration with the UK 
Dementia and Neurodegenerative Diseases Network. 
Patient and public involvement representatives (SN 
and BW- C) were grant co- applicants. Two CRPs ensured 
public involvement at all stages. Each comprised eight 
family carers of people with dementia and a person living 
with dementia, supported by Alzheimer’s Society research 
volunteer network. They collaborated on intervention 
design, recruitment and consent processes, accessibility 
of information leaflets, data collection, interpretation 
and dissemination.
Study population and eligibility criteria
Nursing homes
We recruited 14 NHs (eight in West Yorkshire and six in 
London) with adequate staffing to implement the inter-
vention and support research. These were identified 
via local Clinical Research Networks, and the Enabling 
Research in Care Homes Network, purposively selected 
to include a range of providers (large and small chains, 
independent providers), urban, suburban and rural. 
Managers, regional managers or owners gave written 
permission. The intervention was an enhanced version of 
‘usual care’ implemented at NH level. Therefore, indi-
vidual consent was not required and all staff were involved 
in delivering the intervention to all NH residents.
Individual participants
We invited all English- speaking staff and residents over 
65 years and their carers (family members or friends) 
to participate in individual- level data collection until we 
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each NH. We excluded residents receiving end- of- life 
care or those who did not wish to be involved in research.
Consent procedures
Residents
The NH manager or deputy manager identified all 
potentially eligible residents. If necessary, we conducted 
a capacity assessment regarding trial participation, 
adhering to the UK Mental Capacity Act (2005). If the 
resident lacked capacity, we used a personal consultee 
(friend or family), or if not available, a professional 
consultee (health or social care staff with a professional 
relationship to the resident but no connection with the 
project). If a resident lost capacity during the study, a 
consultee was found.
Family carers and staff
We invited a family carer, and NH staff associated with 
residents recruited to the study, to answer questionnaires 
and they gave informed consent for this.
INTERVENTION
The pilot trial ran for 10 months (November 2017–August 
2018). Sites were set up in months 1 and 2, in month 3 we 
collected pre- intervention (baseline) data over 4 weeks 
before the intervention was implemented. The interven-
tion ran for 6 months with final data collection and site 
closure in month 10. We planned for the trial to run for 16 
months from November 2017 but had to reduce follow- up 
due to delays in obtaining ethical approvals. Thus, timing 
of data collection differs from our protocol.20
Implementation support
This was developed consistent with the PARiHS frame-
work to ensure implementation matched individual 
contexts. It was important for Practice Development 
Champions (PDCs) to decide on how they approached 
this, given the philosophy of quality collaboratives and 
‘champions’ in place. This enhanced the role of PDCs in 
developing their own approach.
Workshop
The research team delivered a 1- day workshop to two 
PDCs from each NH comprising an introduction to four 
key ACSCs (respiratory and UTIs, dehydration, acute 
exacerbation of CHF) and elements of how to bring about 
organisational change. We gave an overview of interven-
tion materials.
Introductory meeting
Researchers held a project initiation meeting with each 
NH manager and available staff to highlight key interven-
tion components, how staff should deliver the interven-
tion and how this may be integrated into existing local 
systems. The PARiHS framework supported PDCs and 
their colleagues to disseminate this information to the 
wider NH staff.
Ongoing implementation support
1. We supported PDCs with a project handbook includ-
ing information on approaches to change used in this 
project; intervention implementation within differing 
contexts; tips to help teams learn and act alongside the 
people for whom they care; and information on en-
hanced leadership capabilities. PDCs were also guided 
through the Practice Development Workbook for Nursing, 
Health and Social Care Teams: Resources for Health and 
Social Care Teams.23
2. We expected PDCs to establish a Practice Development 
Support Group (PDSG) to support their work in the 
NH. This ‘quality collaborative’ approach involves di-
verse stakeholders working together to close the gap 
between actual and potential practice.24
3. The programme manager made weekly contact with 
the PDCs to collect information on how the inter-
vention was working and was available for advice ‘as 
required’. PDCs were offered monthly telephone 
coaching by senior nurse researchers on our team (BM 
and KF).
The intervention (BHiRCH-NH)
This consisted of three key components, adapted from 
the INTERACT programme25 and paper- based as UK 
NHs have variable use of electronic records:
1. Stop and Watch early warning tool: care assistants or nurs-
es used this when they noted a change in a resident’s 
condition. They circled observed changes, notified the 
nurse and placed the tool in the resident’s NH records.
2. Care pathway: this was a two- step clinical guidance 
and decision- support system, focusing on symptoms 
and signs of four key ACSC conditions (acute exacer-
bation of CHF, respiratory and UTIs, dehydration). 
The initial ‘primary’ assessment comprised screening 
questions with the potential to trigger a more detailed 
‘secondary’ assessment. If the primary or secondary as-
sessment result was ambiguous, the care pathway was 
administered at 6- hour intervals, until concerns had 
resolved and/or appropriate intervention was instigat-
ed. The nurse recorded the outcome of the primary 
and secondary assessment and their care plan in the 
resident’s records and decided on the next course of 
action. This may have included further monitoring us-
ing the Stop and Watch early warning tool, treatment 
initiated in the NH, or communication with primary 
care using the Situation, Background, Assessment, 
Recommendation (SBAR) tool. Copies of the complet-
ed care pathway were kept with the resident’s record.
3. The SBAR method: a structured method for commu-
nicating critical information to primary care used by 
nurses to seek primary care intervention for the resi-
dent after the care pathway indicated a risk of decline.
Treatment as usual NHs
Residents received usual care according to existing local 
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A research facilitator, employed by the NH provided 
pseudo- anonymised data at the NH level. We collected 
data for 4 weeks pre- intervention (baseline) including 
staff turnover and the number of beds available to new 
residents. For 4 weeks pre- intervention and then monthly 
for 6 months, we documented the total number of 
contacts with general practitioners (GPs), ambulances, 
accident and emergency (A&E) attendances and hospital 
admissions.
Residents
We collected data pre- intervention on age, gender, 
ethnicity, marital status and highest level of education. 
Functional status was measured using the Barthel Index26 
pre- intervention and at 6 months. We collected data for 
the month pre- intervention and then for the following 
6 months on healthcare use and quality of life (QoL) 
data for health economic analysis, hospital admission 
overall and admissions for the four ACSCs of interest, 
ambulances called, out- of- hours GP visits or telephone 
contacts, A&E attendances and deaths.
Family carers
Pre- intervention we collected data on sociodemographics 
including age, gender, ethnicity and marital status, and 
preferred role, that is, how involved they would like to be 
with the resident’s medical care.
Staff
For contextual understanding we documented pre- 
intervention: staff age, gender, education level and 
characteristics of their work (qualifications, role, length 
of employment, shift pattern and first language). Pre- 
intervention and at 6 months we measured the extent to 
which they perceived the organisation- supported person- 
centred care (Person- Centred Care Assessment Tool 
(P- CAT))27 and the Nurse Ratings of Communication 
with Primary Care Questionnaire.28
Outcomes
We collected data in three domains: (1) individual- level 
data on NH residents, their carers and staff where consent 
had been obtained, (2) system- level data collected by a 
research facilitator to provide pseudo- anonymised data at 
the NH level and (3) process data collected by the study 
team (table 1).
Primary objective
To ascertain whether the intervention was acceptable 
and feasible, we collected data monthly from the NH on 
intervention use in practice: number of ‘Stop and Watch’ 
early warning tools, and primary (initial screening) and 
secondary (more detailed) assessment tools completed. 
Where we had pconsent to collect individual- level resi-
dent data, we monitored participants monthly for 
serious adverse events (SAEs) defined as ‘any untoward 
occurrence that resulted in death, was considered 
life- threatening at the time of the event, required hospi-
talisation or prolongation of existing hospitalisation, 
resulted in persistent or significant disability or incapacity, 
or was any other important medical condition’.
Secondary objectives
1. Establish whether consent procedures facilitate collec-
tion of sufficient individual- level data
We collected data on consent and recruitment rates of 
residents, carers and staff.
2. Assess intervention fidelity
To explore intervention fidelity, two nurse research-
ers aimed to review a convenience sample of five re-
cords for residents admitted to hospital, or received 
treatment in the NH, for ACSCs. They used a free- text 
review sheet to record references to trial intervention 
tools (Stop and Watch, the care pathway and SBAR) 
and assessed compliance with the care pathways. We 
noted where NHs made amendments to the structure 
or content of the care pathway.
3. Assess the effectiveness of the implementation strategy 
and level of staff engagement with the intervention
PDCs were offered monthly telephone coaching for 
advice and to reflect on activities and achievements. 
They kept an activity log of work with PDSGs to doc-
ument the level of facilitation required to support im-
plementation. Qualitative interviews were conducted 
to better understand the barriers and facilitators to 
implementation. Learning from the implementation 
strategy will be presented in a separate paper.
4. Indicate whether the intervention would be sustain-
able outside the trial context
Data from objectives 2–3 were considered by the inde-
pendent project steering group at the end of the study.
5. Assess potential primary and secondary outcomes for 
a definitive trial
To explore the impact of enhanced healthcare in the 
NH, we documented hospital admissions for the four 
key ACSCs (acute exacerbation of CHF, respiratory 
and UTIs, dehydration). Number (%) of residents 
requiring one or more ambulance calls, one or more 
unscheduled out- of- hours GP visits or phone calls, and 
having one or more A&E department visits were docu-
mented as potential secondary outcomes.
We tested the assumption that a hospitalisation for an 
ACSC was a proxy for an avoidable hospital admission 
using the Structured Implicit Record Review (SIRR) 
tool.29 Two independent experts (geriatrician and 
community nurse) used the SIRR, which takes account 
of the resident’s pre- existing health, any advance direc-
tives and the care options available at the time to assess 
the ‘avoidability’ of the admission.
6. Measure completeness of data collection and docu-
mentation, return rate of questionnaires
We assessed completeness of outcome measures, data 
collection and return rate of questionnaires.
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We collected data on resident service use with the 
Client Service Receipt Inventory (CSRI),30 complet-
ed pre- intervention and then monthly for 6 months. 
Data on QoL were collected using the self- completed 
EQ- 5D- 5L31 questionnaire where participants had the 
capacity to do this. Where a resident could not com-
plete the EQ- 5D- 5L questionnaire, the proxy version 
was completed by the carer or a member of staff. We 
Table 1 Summary of data collected, outcome measures and time schedule
Data collected and tool used Pre- intervention Monthly 6 months
Resident
Sociodemographics Age, gender, ethnicity, marital status, highest level of 
education
S – –
Service use in the prior month Client Service Receipt Inventory, calculates service 
and total care costs
S S –
Functional status The Barthel Index S – S
Resident quality of life (QoL)—
self- rated
EQ- 5D- 5L self- rated health index and Visual 
Analogue Scale of current health state
P – P




Sociodemographics Age, gender, ethnicity, marital status, years of 
schooling, highest level of education
FC – –
QoL EQ- 5D- 5L FC – FC




Staff sociodemographics Age, gender, ethnicity, number of years of education R – –
Staff work characteristics Highest qualification, role in nursing home, length of 
service, shift pattern, first language
R – –
Organisational support for 
person- centred care
The Person- Centred Care Assessment Tool S – S
Communication with primary 
care
Nurse–GP Communication Needs Assessment 
Questionnaire
S – S
Perceived knowledge and 
skills for early detection in 
changes in health
Developed from feasibility study; assesses key 
knowledge and skills needed to implement the 
intervention; rated on 5- point Likert scale
S – S
System- level data
Number of hospital admissions Respiratory infection, exacerbation of CHF, UTI and 
dehydration
S S –
‘Avoidability’ of admissions Structured Implicit Record Review (Saliba et al, 
2000)
S S –
Use of primary assessment 
tool
Respiratory infection, exacerbation of CHF, UTI and 
dehydration
S S –
Use of secondary assessment Respiratory infection, exacerbation of CHF, UTI and 
dehydration
S S –
Out- of- hours GP contacts GP visits or telephone contact S S –
Ambulances and hospital use Number of hospital admissions, A&E attendances 
and readmissions
S S –
Deaths in the last calendar 
month
  S S –
Staff turnover   S – –
Nursing home occupancy level Number of available beds to new residents S – –
Measure assessed by: P, participant; FC, family carer; R, researcher; S, nursing home staff.
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also collected data on carer QoL using the EQ- 5D- 
5L questionnaire. All QoL data were collected pre- 
intervention and at 6 months.
Sample size
This was a pilot study so no sample size calculation was 
conducted. The number of NHs was chosen on prag-
matic grounds to allow testing of study procedures and 
variability in settings.
Randomisation
NHs were randomised prior to intervention: four in West 
Yorkshire and three in Greater London (seven total) 
to the intervention and four in Yorkshire and three in 
Greater London (seven total) to ‘usual care’, stratified by 
location. We used the SAS version 9.4 statistical program 
to generate a randomisation list drawn up by a clinical 
trials unit statistician not involved in the study.
Blinding
This was not feasible for staff collecting data. Statisticians 
and health economists were blinded to allocation. The 
randomisation variable was supplied to them unlabelled, 
and the main analysis was completed using this.
Data management
Data were entered onto paper case report forms and 
then into an encrypted password- protected database in 
accordance with the UK Data Protection Act and General 
Data Protection Regulation. We followed a standardised 
process for database lock.
Statistical methods
As a pilot study, analyses are mainly descriptive (counts, 
means, SD, medians with IQR) focusing on recruitment, 
participant characteristics, other baseline and outcome 
variables, loss to follow- up and tabulation of SAEs. We 
summarised completeness of data on outcome measures 
and questionnaire response rates.
Economic evaluation
We calculated costs associated with the intervention, 
including costs of staff training and implementation. 
Resources use associated with hospital admissions, 
primary care, and National Health Service (NHS) and 
social care services were collected using the CSRI and 
costed from the NHS/personal social services perspec-
tive.32–34 All costs are reported in 2016/2017 British 
pounds (£). Quality- adjusted life years (QALYs) for resi-
dents were calculated using the EQ- 5D- 5L questionnaire 
and associated algorithms mapping the 5L descriptive 
system data onto the 3L valuation set as recommended by 
the National Institute for Health and Care Excellence.35–38 
We report only results based on QALYs calculated using 
the resident self- completed EQ- 5D- 5L questionnaire as 
these had higher return. There was no discounting of 
costs or QALYs given they were reported over 6 months 
only. For missing data we used multivariate imputation 
by chained equation, generating 20 imputed data sets. 
For each of these, we ran 1000 bootstrap replications 
using non- parametric bootstrapping. Bootstrap results 
were combined to calculate the mean values for costs 
and utilities and the SEs around the imputed values used 
to calculate 95% CI around point estimates. To report 
the probability that the intervention is cost- effective 
compared with treatment as usual (TAU) for a range of 
values of willingness to pay (WTP) for a QALY gained, 
the bootstrap results have been used to generate a cost- 
effectiveness acceptability curve39 and the probability that 
the intervention is cost- effective compared with TAU at a 
£20 000 for a QALY gained reported.
RESULTS
Here, we give trial results with full data given in the supple-
mental appendices to ensure transparency of reporting. 




We recruited the target number of 14 NHs and randomised 
as planned: seven intervention (three London, four York-
shire) and seven control (three London and four York-
shire). One Yorkshire intervention NH was closed by 
its owners and dropped out pre- intervention. A further 
intervention NH in London dropped out following PDC 
training as they were unable to implement the interven-
tion. Most NHs were privately managed with a median 
50 residents (IQR 34–68). The majority (73%) were 
‘dementia registered’. In terms of Care Quality Commis-
sion (CQC) ratings, 1 home (7%) was ‘outstanding’, 
11 (79%) ‘good’ and 2 (14%) ‘required improvement’ 
(online supplemental appendix 1).
Residents
We recruited 237 residents (figure 1), two- thirds were 
women, predominantly white (90%) with a median age 
of 86 years (IQR 80–91).
The median Barthel Index score was low at 27 (IQR 
9–64) indicating a high level of dependency in activities 
of daily living. Only 6 residents (3%) had an admission 
for an ACSC in the pre- intervention period, 11 (5%) resi-
dents had at least one ambulance called and 12 (5%) had 
an unscheduled GP visit or telephone contact (table 2).
Family carers
We recruited 91 family carers, two- thirds were women 
(table 2, online supplemental appendix 2). Median age 
was 63 years (IQR 57–71). Most (91%) wished to be 
involved in noticing early changes in the resident’s health.
Staff
We recruited 132 staff (online supplemental appendix 3), 
with a median age of 42 years (IQR 30–53), 12% were 
men, 50% of nurses spoke English as a first language and 
59% of staff described themselves as white. Most staff 
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30% were qualified nurses. Scores on the P- CAT scale 
(possible range 13–65) were generally positive with a 
median score of 49 (IQR 46–53) (online supplemental 
appendix 4). Most nurses were positive about the quality 
of communications they had with GPs (online supple-
mental appendix 5) and their self- rated knowledge and 
skills (online supplemental appendix 6).
Primary objective: feasibility and acceptability
Use of the intervention
Across the 5 intervention NHs, only 16 Stop and Watch 
forms were completed of which 11 came from a single 
NH. Eight care pathways were reported as completed but 
only three were located by the study team. There was a 
median of one Stop and Watch form (IQR 0–3) and a 
median of zero care pathways (IQR 0–2) completed per 
month. In a few cases, routine clinical observations (eg, 
temperature, blood pressure and so on) were carried out, 
but not reported systematically or presented as part of 
a coherent assessment plan. One home had a policy of 
recording routine observations once per month.
Serious adverse events
There were no differences in SAEs between TAU and 
intervention groups. There were 104 SAEs in 74 residents 
during the study and 33 residents died (19 TAU and 
14 intervention). Of the 104 SAEs, hospitalisation (any 
cause) was the most common (N=50) (online supple-
mental appendix 7).
Figure 1 Resident recruitment flowchart.
Table 2 Characteristics of residents and family carers
Characteristic
Cohort TAU BHiRCH- NH
n or median (% or IQR)
Residents
Demographics N=234 N=137 N=97
  Male 73 (31) 46 (34) 27 (28)
  Age 86 (80–91) 86 (80–91) 84 (78–91)
Ethnicity N=225 N=131 N=94
  White 203 (90) 117 (89) 86 (91)
  Black 14 (6) 9 (7) 5 (5)
  Asian 5 (2) 4 (3) 1/(1)
  Other 3 (1) 1 (1) 2 (2)
Marital status N=223 N=127 N=96
  Married or 
cohabiting
49 (22) 28 (22) 21 (22)
  Single 59 (26) 40 (32) 19 (20)
  Divorced or 
widowed
115 (52) 59 (46) 56 (58)
Education N=184 N=133 N=71
  Completed 
years of 
education
11 (9–12) 11 (10–12) 11 (9–11)
  No 
qualifications 
or GCSE or 
equivalent
107 (58) 63 (56) 44 (62)
  A Level/NVQ/
HNC/HND or 
equivalent
18 (10) 11 (10) 7 (10)
  Degree or 
higher degree
23 (13) 14 (12) 9 (13)
  Other 
qualification
36 (20) 25 (22) 11 (15)
Function
  Barthel Index 
score
27 (9–64) 27 (9–66) 30 (8–63)
Carers
Demographics N=91 N=56 N=35
  Male 31 (34) 17 (30) 14 (40)
  Age 63 (57–71) 62 (57–71) 64 (58–74)
Ethnicity N=87 N=52 N=35
  White 72 (83) 43 (83) 29 (83)
  Black 12 (14) 7 (13) 5 (14)
  Asian 3 (3) 2 (4) 1 (3)
Marital status N=87 N=53 N=34
  Married or 
cohabiting
65 (75) 36 (68) 29 (85)
  Single 10 (11) 8 (15) 2 (6)
  Divorced or 
widowed
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Secondary objectives
1. Resident consent procedures and collection of suffi-
cient individual level data
We screened 680 residents, 557 met eligibility criteria 
and 245 were recruited (35% recruitment). Taking 
into account that two NHs dropped out, leaving 12 in 
the study, we reached our target of 240 residents (20 
residents per NH). Most eligible residents (364, 65%) 
did not have capacity to consent to participate in the 
study. Of recruited residents, 73% completed the study 
(online supplemental appendix 8).
2. Assess intervention fidelity
It was not possible to assess fidelity to the intervention 
as the intervention was not implemented as intended 
and the documentation required to assess fidelity was 
not available.
3. Assess the effectiveness of the implementation strategy 
and level of NH staff engagement with the intervention
The implementation strategy was not effective and NH 
staff did not engage with or use the intervention tools. 
Data and learning from implementation will be pre-
sented in a separate paper.
4. Investigate whether the intervention would be sustain-
able outside the context of a trial
The intervention was not widely used; 16 Stop and 
Watch forms were completed and we found 8 complet-
ed care pathway documents. We concluded the inter-
vention in its current form was not sustainable.
5. Assess potential primary and secondary outcome mea-
sures for a definitive trial
Rates of hospitalisation for ACSCs
At baseline the rates of hospitalisation for ACSCs (res-
piratory infection, exacerbation of CHF, UTI and de-
hydration), our potential primary outcome, were low 
and 0.4% of the cohort had an admission for respira-
tory infections, 1% for UTI, none for dehydration and 
0.4% had an admission for CHF in the month before 
the trial started. There were six admissions in total 
from the 235 residents in the study. Considering the 
whole 6- month study period, 25 study participants 
(15%) had an unplanned hospital admission for one 
of the ACSCs. The low rates of unplanned hospital 
admission (per 100 person months) for these ACSCs 
suggest this is not an optimal primary outcome meas-
ure for future studies table 3). Considering secondary 
outcome measures for a definitive trial, we found a 
slightly higher proportion of participants (n=38, 16%) 
had an A&E attendance during the follow- up period, 
42 (18%) had at least one ambulance called, 29 (12%) 
had an unscheduled (out- of- hours) GP visit and 21 
(11%) died. The incidence of these events was still rel-
atively low and not sufficiently frequent to be definitive 
study outcomes.
Hospitalisation for an ACSC as a proxy for avoidable hospital 
admission
We intended to use the SIRR tool to assess the appro-
priateness of 30 resident admissions for one of the 
four ACSCs, but it was not always possible to identify 
the reasons for admission and these were low overall. 
We therefore expanded our sample to include hospi-
tal admissions for any cause. One NH had no eligible 
residents, because those admitted to hospital had died 
and/or their care records were no longer available. We 
therefore also included residents who died in hospital, 
as long as their records were still available. We were 
Characteristic
Cohort TAU BHiRCH- NH
n or median (% or IQR)
Education N=86 N=53 N=33
  Completed 
years of 
education
11 (11–12) 12 (11–13) 11 (11–12)
  No 
qualifications 
or GCSE or 
equivalent
35 (41) 21 (40) 14 (42)
  A Level/NVQ/
HNC/HND or 
equivalent
13 (15) 9 (17) 4 (12)
  Degree or 
higher degree
26 (30) 14 (26) 12 (36)
  Other 
qualification
12 (14) 9 (17) 3 (9)
Preferred role N=87 N=52 N=35
  Noticing 
early signs of 
changes in 
health
79 (91) 49 (94) 30 (86)
  Informing 
staff about 
early signs of 
changes in 
health
77 (89) 48 (92) 29 (83)







51 (59) 28 (54) 23 (66)






57 (66) 33 (63) 24 (69)
  Prefer not to 
be involved
5 (6) 2 (4) 3 (9)
  Other 18 (21) 9 (17) 9 (26)
BHiRCH- NH, Better Health in Residents of Care Homes with 
Nursing; GCSE, General Certificate of Secondary Education; HNC, 
Higher National Certificate; HND, Higher National Diploma; NVQ, 
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able to assess 10 admissions from a total of 24, which 
occurred during the study period. Using the SIRR tool, 
we deemed 3 of the 10 admissions assessed potential-
ly avoidable. None of the NH care records provided 
a complete picture of residents’ health in the period 
leading up to admission. This suggested an ACSC ad-
mission was not a reliable proxy measure for an ‘avoid-
able admission’.
6. Completeness of data collection and documentation, 
return rate of questionnaires
Care staff- related data
We collected data on most recruited care staff at base-
line (N=132). For example, 129 care staff gave demo-
graphic details (98%) and 127 (96%) completed the 
P- CAT scale. Attrition in response to these scales was 
secondary to NHs dropping out of the study, rather 
than staff being unwilling or unable to complete them.
Resident- related data
Demographic and functional ability data were availa-
ble on most residents at baseline (N=235) including 
gender (99%), ethnicity (95%), marital status (98%) 
and Barthel Index (98%). We cannot be sure that no 
admissions or visits to acute hospital were missed as 
NHs did not have centralised systems for collecting 
these data.
7. Cost and outcome data for use in an economic eval-
uation, key cost components and probability of 
cost- effectiveness
One NH withdrew after randomisation and therefore, 
we considered the cost of intervention to be £0 (as 
‘per randomised’ approach). Assuming the interven-
tion was offered to all 89 residents randomised to the 
intervention group, the mean cost per resident would 
be £74 (95% CI £64 to £84). During follow- up, there 
were no significant differences in the majority of the 
components of healthcare resource use between the 
intervention and TAU groups (online supplemental 
appendices 9 and 10). Differences in mean utility val-
ues and QALYs were not statistically significant when 
carers assessed their QoL and therefore, no further 
Table 3 System- level outcome data
Pre- intervention Over 6- month follow- up period
Whole cohort TAU BHiRCH- NH TAU BHiRCH- NH
n or median (% or (IQR)
Study cohort N=235 N=139 N=96 N=139 N=96
At least one admission in the last month 6 (3) 2 (1) 4 (4) 19 (14) 16/96
Respiratory infection admission 1 (0.4) 0 1 (1) 8 (6) 5/96
Urinary tract infection admission 2 (1) 1 (1) 1 (1) 5 (4) 2/96
Dehydration admission 0 0 0 0 1/96
Congestive heart failure admission 1 (0.4) 0 1 (1) 0 1/96
At least one ambulance called 11 (5) 4 (3) 7 (7) 20 (14) 22/96
At least one out- of- hours GP visit or telephone 
contact
12 (5) 11 (8) 1 (1) 14 (10) 15/96
At least one accident and emergency 
attendance
10 (4) 6 (4) 4 (4) 17 (12) 21/96
Died 1 (0.4) 1 (1) 0
Nursing home data
Number of hospital admissions 3 (2–5) 4 (2–7) 3 (2–4) 12 (12–16) 12 (7–18)
Number of ambulances called 3 (2–6) 4 (2–9) 3 (2–6) 12 (11–17) 19 (7–22)
Unscheduled (out- of- hours) GP visits or 
telephone contacts
1 (1–3) 2 (1–3) 1 (1–3) 8 (7–13) 9 (4–25)
Accident and emergency attendances 3 (2–5) 3 (1–4) 3 (2–6) 12 (11–13) 8 (7–13)
Rate of hospital admissions per 100 person 
months
– – 5.3 (2.3–8.3) 5.9 (1.7–7.1)
Rate of ambulances called per 100 person 
months
– – 5.7 (2.3–8.0) 6.0 (2.0–9.3)
Rate of unscheduled (out- of- hours) GP visit or 
contacts per 100 person months
– – 2.5 (1.8–4.0) 5.1 (1.1–6.0)
Rate of accident and emergency attendances 
per 100 person months
– – 4.3 (2.5–8.3) 3.9 (2.0–5.6)
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analysis was performed. The mean total cost of health-
care resource use/resident over 6 months was £1458 
(95% CI £1351 to £1566) in the intervention group 
and £1233 (95% CI £1171 to £1295) in the TAU group 
(online supplemental appendix 11). Non- parametric 
bootstrapping after multiple imputation produced a 
mean total cost per resident in the intervention group 
of £1479 (95% CI £757 to £2200), compared with 
£1271 (95% CI £975 to £1566) in the TAU group. The 
mean difference in cost between the BHiRCH- NH and 
TAU group was £208 (95% CI −£561 to £977). Non- 
parametric bootstrapping after multiple imputation 
produced 0.315 (95% CI 0.304 to 0.326) QALYs in the 
intervention group and 0.298 (95% CI 0.290 to 0.307) 
QALYs in the TAU group, generating a statistically sig-
nificant mean difference in QALYs of 0.016 (95% CI 
0.003 to 0.300) (table 4).
The incremental cost per QALY gained of BHiRCH- NH 
versus TAU was £12 633. Residents receiving the interven-
tion accrued a non- significantly higher cost and a very 
small increase in QALYs; the intervention has a 65% 
probability of being cost- effective at a WTP of £20 000 
(online supplemental appendix 12).
DISCUSSION
Our cluster randomised pilot trial of the BHiRCH- NH 
intervention in 12 NHs found study processes were effec-
tive. We successfully recruited, retained and obtained 
individual- level data from residents, staff and family 
carers. Adverse event data did not suggest the interven-
tion caused harm. Our CRP worked with us throughout, 
advising on study set- up, engaging with homes and poten-
tial participants, data collection, and contributing to data 
analysis and interpretation. However, despite excellent 
recruitment and retention, there was limited engagement 
with the intervention tools and the support offered for 
their implementation. The lack of use of the intervention 
coupled with the economic analysis means that we would 
not recommend a definitive randomised controlled trial 
of the BHiRCH- NH intervention. We focused on four key 
ACSCs (dehydration, respiratory and UTIs, and exacerba-
tion of CHF) because they are common causes of poten-
tially avoidable hospital admissions and a significant area 
of health policy focus. There is lack of national compar-
ative data, but we found lower hospitalisation rates for 
these conditions than we expected. Categorising admis-
sions to hospital is complex and people may present with 
broader symptoms that is, delirium or falls. ACSCs may 
be more of an administrative label to be used in large 
data analyses rather than a sensitive tool for assessing the 
‘avoidability’ or otherwise of acute hospital admissions.
Implementing practice change in NHs can be chal-
lenging. Despite offering monthly telephone support 
calls during the study at times agreed with PDCs, they 
often could not speak due to changes in duty rosters, last- 
minute leave or being too busy. While the INTERACT 
programme, from which our BHiRCH- NH intervention 
was adapted, demonstrated reductions in all- cause hospi-
talisations among actively participating NHs, a subsequent 
larger randomised controlled implementation trial in 85 
US NHs had no effect on emergency department visits 
or hospital admissions.14 Resources, competing demands 
and instability of NH leadership were all barriers to 
successful INTERACT implementation,40 and it is likely 
that these factors were also present in our study.
Our study has limitations. We recruited NHs, residents, 
staff and family carers to target, although two NHs dropped 
out from the intervention arm. Our NHs may be atypical 
as 79% were rated as ‘good’ by the CQC, compared with 
the UK national average of 73%. Residents in our sample 
were broadly representative of the UK NH population in 
terms of age and gender.41 Monthly visits from research 
fieldworkers and the appointment of research facilitators 
who were existing NH staff fostered positive relationships 
between NHs and the research team and facilitated access 
to NH records. We cannot verify that data on hospital 
attendances, staffing and support from external health-
care services are complete, as most NHs did not routinely 
record hospital admissions or ambulance and GP call- 
outs. Staff self- rated their knowledge and skills regarding 
health conditions and their communication with primary 
care and research assistants collecting outcome data were 
not blind to NH allocation. We assumed we could use 
admission for ACSCs as a proxy for avoidable admissions, 
but even after using the SIRR tool,42 it was difficult to 
identify whether an admission was for an ACSC or not. 
Future studies should include consent to access hospital 
records so this can be more thoroughly assessed.
Current UK policy focus on reducing hospitalisations 
and enhanced healthcare in NHs has led to significant 
levels of activity in local health and social care services. 
Research in such a fast- moving landscape is challenging. 
NHS England’s demonstration projects ‘Vanguards’ and 
increasing numbers of local quality improvement initia-
tives means ‘usual care’ will be improving, making trials 
challenging to conduct. Although our intervention was 
Table 4 Cost- effectiveness of BHiRCH- NH intervention 
versus TAU: complete case and imputed data analyses
Incremental cost QALY gained
Mean (95% CI) Mean (95% CI)
Base 
case*
£208 −£561 to £977 0.016 0.003 to 0.300
Complete 
case†
£352 −£745 to £1448 0.018 −0.012 to 0.048
*Data include values imputed using multiple imputation with SEs 
corrected to account for uncertainty in the imputed values. QALYs 
gained are adjusted for baseline utility values and nursing home 
clustering. The incremental costs are adjusted for costs in the 
1- month period prior to baseline and nursing home clustering.
†As for the base case analysis except there is no multiple 
imputation for missing data.
BHiRCH- NH, Better Health in Residents of Care Homes with 
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co- designed with staff, this involved an extra burden of 
observation and documentation, which was difficult for 
staff who were already pressed for time. Recent studies 
conducted in care homes suggest that a higher level of 
support and facilitation may be required for effective 
implementation; meetings involving all NH staff may be 
more successful.43 The Palliative Care for Older People 
Steps to Success Programme conducted in 78 NHs across 
seven countries, which involved a complex intervention 
to improve end- of- life care, did not improve resident 
comfort or staff knowledge despite using a train- the- 
trainer approach.44 However, the Well- Being and Health 
for People with Dementia programme was successfully 
implemented in 69 UK care homes and showed a signifi-
cant effect on reducing agitation possibly through a much 
higher intensity of external facilitation that may not be 
sustainable or cost- effective.45 Since we designed our 
intervention and conducted our pilot trial, knowledge 
on improving healthcare for NH residents has increased. 
Key components for resident healthcare, identified in the 
2017 ‘Optimal’ study were GP involvement supported by 
integrated external services.46 These findings are reflected 
by emerging evidence that change to the wider health 
and social care system may be more effective in reducing 
the number of NH residents admitted to hospital.47
CONCLUSIONS
Our co- designed complex intervention for early detec-
tion, monitoring and communication of change in 
residents’ health does not warrant a future definitive 
trial because it was not implemented in practice. It was 
important that this pilot trial was conducted as this has 
avoided the risk of embarking on a full trial and subse-
quent waste of resources and time.48 Our study contrib-
utes to learning in the under- researched but vital field of 
NH research.
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